2,4,5- three fluoro acetic acid is a white solid used to synthesize the intermediate of sitagliptin, a new drug for the treatment of type II diabetes. Sitagliptin is the first DPP-IV inhibitor of Merck company. It has good efficacy, side effects, safety and tolerance, and has broad market prospects.
CRO
